Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation

Annals of Hematology

Volumn 92, Issue 2, 2013, Pages 255-260

  Oshima, Kumi ^a   Kanda, Yoshinobu ^a   Nanya, Yasuhito ^b   Tanaka, Masatsugu ^c   Nakaseko, Chiaki ^d   Yano, Shingo ^e   Fujisawa, Shin ^f   Fujita, Hiroyuki ^g   Yokota, Akira ^h   Takahashi, Satoshi ^b   Kanamori, Heiwa ^c   Okamoto, Shinichiro ⁱ  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^g YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^h CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

ⁱ KEIO UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; HSCT; Reduced renal function

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLE SIZE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; CALCINEURIN; COMORBIDITY; CREATININE; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY TRANSPLANTATION; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872285910     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1584-1     Document Type: Article

References (20)

1. Heher EC, Spitzer TR (2010) Hematopoietic stem cell transplantation in patients with chronic kidney disease. Semin Nephrol 30(6):602-614. doi: 10.1016/j.semnephrol.2010.09.008
2. Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, Maloney DG, Deeg HJ, Appelbaum FR, Storer B, Storb R (2007) Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110(13):4606-4613. doi: 10.1182/blood-2007-06-096966
3. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912-2919. doi: 10.1182/blood-2005-05-2004
4. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-266
5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113:S1-130
6. Stevens LA, Li S, Kurella Tamura M, Chen SC, Vassalotti JA, Norris KC, Whaley-Connell AT, Bakris GL, McCullough PA (2011) Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 57(3 Suppl 2):S9-S16. doi: 10.1053/j.ajkd.2010.11.007
7. Gray RJ (1988) A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154
8. Fine JP, Gray RJ (1999) A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 94:456-509
9. Kanda Y (2012) Free statistical software: EZR (Easy R) on R commander. http://www.jichi.ac.jp/saitama-sct/SaitamaHP.files/statmedEN.html. Accessed 1 March 2012
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373-383
11. Hoek FJ, Kemperman FA, Krediet RT (2003) A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 18(10):2024-2031. doi: 10.1093/ndt/gfg349
12. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65(4):1416-1421. doi: 10.1111/j.1523-1755.2004.00517.x
13. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75(6):652-660. doi: 10.1038/ki.2008.638
14. Parikh CR, Coca SG (2006) Acute renal failure in hematopoietic cell transplantation. Kidney Int 69(3):430-435. doi: 10.1038/sj.ki.5000055
15. Zager RA, O'Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, Stewart P, Thomas ED (1989) Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 13(3):210-216
16. Hingorani SR, Guthrie K, Batchelder A, Schoch G, Aboulhosn N, Manchion J, McDonald GB (2005) Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int 67(1):272-277. doi: 10.1111/j.1523-1755.2005.00078.x
17. Zager RA, Andoh T, Bennett WM (2001) Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol 159(2):743-752. doi: 10.1016/S0002-9440(10)61745-2
18. Zager RA, Shah VO, Shah HV, Zager PG, Johnson AC, Hanson S (2002) The mevalonate pathway during acute tubular injury: selected determinants and consequences. Am J Pathol 161(2):681-692. doi: 10.1016/S0002-9440(10)64224-1
19. Zager RA (2010) Acquired cytoresistance in the setting of hematopoietic cell transplantation. Clin J Am Soc Nephrol 5(12):2150-2153. doi: 10.2215/CJN.07780910
20. Kersting S, Verdonck LF (2008) Chronic kidney disease after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant 14(4):403-408. doi: 10.1016/j.bbmt.2007.12.495